Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Prognostic Factors for Tubo-ovarian Cancer in France: Surgical Thresholds, Geographical Distance, Age and Therapeutic Sequence

NCT05204342 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT05204342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05204342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Prognostic Factors for Tubo-ovarian Cancer in France: Surgical Thresholds, Geographical Distance, Age and Therapeutic Sequence
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Completed
Start date
January 1, 2012
Completion date
December 30, 2021
Enrollment
22,500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer